All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

More...

Supplementation Effects of an Alpha-Casozepine and White Fish Muscle Hydrolyzed Complementary Feed on Canine Separation-Related Disorders and Quality of Life of Dogs and Their Pet Caregivers

DOI: 10.4236/ojvm.2023.136007, PP. 68-81

Keywords: Alpha-Casozepine, Fish Muscle Hydrolysate, Canine Separation-Related Disorders, Dogs

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Separation-related disorders are prevalent in dogs and can result in problem behaviours such as inappropriate elimination, destructive behaviour, and distress vocalizations which occur when a caregiver is absent or perceived as absent. Numerous natural products are marketed for managing these behavioural issues in dogs; however, few, if any, of these products have documented evidence of their positive effects in veterinary behaviour. Purpose: This open, multicentric clinical trial aimed to assess the effect of a new supplement containing alpha-casozepine and fish muscle hydrolysate on the separation-related problem in dogs and the impact on the quality of life of dogs and their caregivers. Material and Methods: Fifty-one dogs with clinical signs compatible with separation-related problems were included. The dogs were supplemented with a complementary feed (Zylkene Plus, Vetoquinol, France) for 30 days. Separation-related behaviour assessment (SRP), emotional disorders assessment (EDED) and the quality of life (QoL) of the pets and their pet caregivers were assessed at baseline and at the end of the study by the veterinarians. In addition, caregivers were asked to rate their dog’s SRP weekly after enrolment using the same questionnaire that the veterinarian used at the beginning of the study. Results: There was a statistically significant improvement in the SRP, EDED, and QoL scores (P < 0.0001). The mean global SRP score decreased by 32% between baseline and D7, 41% between DO and D14, 47% between D0 and D D21, and 49% between D0 and D30. The percentage of dogs in a normal state (EDED < 12) increased during the study from 26% in D0 to 62% at D30, and the percentage of dogs with scores related to anxieties decreased from 40% at D0 to 17% at D30. On day 30, there were significant improvements in QOL scores compared to the baseline. Conclusion: The results of this study support the hypothesis that the combination of alpha-casozepine and fish muscle hydrolysate is a promising and effective option to reduce the frequency and severity of separation-related behaviour in dogs and improve the quality of dogs and their caregivers.

References

[1]  Bradshaw, J. (2011) In Defence of Dogs: Why Dogs Need Our Understanding. Penguin Press, London.
[2]  Sargisson, R.J. (2014) Canine Separation Anxiety: Strategies for Treatment and Management. Veterinary Medicine: Research and Reports, 5, 143-151.
https://doi.org/10.2147/VMRR.S60424
[3]  Sherman, B.L. and Mills, D.S. (2008) Canine Anxieties and Phobias: An Update on Separation Anxiety and Noise Aversions. Veterinary Clinics of North America: Small Animal Practice, 38, 1081-1106.
https://doi.org/10.1016/j.cvsm.2008.04.012
[4]  Tod, E., Brander, D. and Waran, N. (2005) Efficacy of Dog Appeasing Pheromone in Reducing Stress and Fear Related Behaviour in Shelter Dogs. Applied Animal Behaviour Science, 93, 295-308.
https://doi.org/10.1016/j.applanim.2005.01.007
[5]  King, J.N., Simpson, B.S., Pageat, P., Overall, K.L., Appleby, D., Pageat, P., Ross, C., Chaurand, J.P., Heath, S., Beata, C., Weiss, A.B., Muller, G., Paris, T., Bataille, B.G., Parker, J., Petit, S., Wren, J. and The CLOCSA Group (2000) Treatment of Separation Anxiety in Dogs with Clomipramine: Results from a Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial. Applied Animal Behaviour Science, 67, 255-275.
https://doi.org/10.1016/S0168-1591(99)00127-6
[6]  Sari, A., Fukuda, Y., Sakada, T., Maekawa, T. and Ishikawa, T. (1975) Effects of Psychotropic Drugs on Canine Cerebral Metabolism and Circulation Related to EEG—Diazepam, Clomipramine and Chlorpromazine. Journal of Neurology, Neurosurgery, and Psychiatry, 38, 838-844.
https://doi.org/10.1136/jnnp.38.9.838
[7]  Sanchez-Araujo, M. and Puchi, A. (2011) Acupuncture Prevents Relapses of Recurrent Otitis in Dogs: A 1-Year Follow-Up of a Randomized Controlled Trial. Acupuncture in Medicine, 29, 21-26.
https://doi.org/10.1136/aim.2010.002576
[8]  Kidd, J.R. (2012) Alternative Medicines for the Geriatric Veterinary Patient. Veterinary Clinics of North America: Small Animal Practice, 42, 809-822.
https://doi.org/10.1016/j.cvsm.2012.04.009
[9]  Chapman, S.F. (2011) Homeopathic and Integrative Treatment for Feline Hyperthyroidism—Four Cases 424 (2006-2010). Homeopathy, 100, 270-274.
https://doi.org/10.1016/j.homp.2011.05.004
[10]  Neumann, S., Stolt, P., Braun, G., Hellmann, K. and Reinhart, E. (2011) Effectiveness of the Homeopathic Preparation Zeel Compared with Carprofen in Dogs with Osteoarthritis. Journal of the American Animal Hospital Association, 47, 12-20.
https://doi.org/10.5326/JAAHA-MS-5483
[11]  Gingerich, D.A. and Strobel, J.D. (2003) Use of Client-Specific Outcome Measures to Assess Treatment Effects in Geriatric, Arthritic Dogs: Controlled Clinical Evaluation of a Nutraceutical. Veterinary Therapeutics, 4, 376-386.
[12]  Araujo, J.A., Landsberg, G.M., Milgram, N.W. and Miolo, A. (2008) Improvement of Short-Term Memory Performance in Aged Beagles by a Nutraceutical Supplement containing Phosphatidylserine, Ginkgo biloba, Vitamin E and Pyridoxine. Canadian Veterinary Journal, 49, 379-385.
[13]  Kato, M., Miyaji, K., Ohtani, N. and Ohta, M. (2012) Effects of Prescription Diet on Dealing with Stressful Situations and Performance of Anxiety-Related Behaviors in Privately Owned Anxious Dogs. Journal of Veterinary Behavior, 7, 21-26.
https://doi.org/10.1016/j.jveb.2011.05.025
[14]  Wells, D.L. (2006) Aromatherapy for Travel-Induced Excitement in Dogs. Journal of the American Veterinary Medical Association, 229, 964-967.
https://doi.org/10.2460/javma.229.6.964
[15]  Makawey, A., Iben, C. and Palme, R. (2020) Cats at the Vet: The Effect of Alpha-s1 Casozepin. Animals, 10, Article 2047.
https://doi.org/10.3390/ani10112047
[16]  Miclo, L., Perrin, E., Driou, A., Papadopoulos, V., Boujrad, N., Vanderesse, R., Boudier, J.F., Desor, D., Linden, G. and Gaillard, J.L. (2001) Characterization of α-Casozepine, a Tryptic Peptide from Bovine αs1-Casein with Benzodiazepine-Like Activity. The FASEB Journal, 15, 1780-1782.
https://doi.org/10.1096/fj.00-0685fje
[17]  Messaoudi, M., Lefranc-Millot, C., Desor, D., Demagny, B. and Bourdon, L. (2004) Effects of a Tryptic Hydrolysate from Bovine Milk αs1-Casein on Hemodynamic Responses in Healthy Human Volunteers Facing Successive Mental and Physical Stress Situations. European Journal of Nutrition, 44, 128-132.
https://doi.org/10.1007/s00394-004-0534-7
[18]  Vøls, K.K., Heden, M.A., Kristensen, A.T. and Sandøe, P. (2017) Quality of Life Assessment in Dogs and Cats Receiving Chemotherapy—A Review of Current Methods. Veterinary Comparative Oncology, 15, 684-691.
https://doi.org/10.1111/vco.12242
[19]  Dinel, A.L., Lucas, C., Le Faouder, J., Bouvret, E., Pallet, V., Layé, S. and Joffre, C. (2021) Supplementation with Low Molecular Weight Peptides from Fish Protein Hydrolysate Reduces Acute Mild Stress-Induced Corticosterone Secretion and Modulates Stress Responsive Gene Expression in Mice. Journal of Functional Foods, 76, Article ID: 104292.
https://doi.org/10.1016/j.jff.2020.104292
[20]  Bernet, F., Montel, V., Noël, B. and Dupouy, J.P. (2000) Diazepam-Like Effects of a Fish Protein Hydrolysate (Gabolysat PC60) on Stress Responsiveness of the Rat Pituitary-Adrenal System and Sympathoadrenal Activity. Psychopharmacology, 149, 34-40.
https://doi.org/10.1007/s002139900338
[21]  Braat, K.M. and Brinker, C.J. (2004) GABA (B) Receptors: Pharmacology and Therapeutic Potential. Current Opinion in Pharmacology, 4, 12-18.
[22]  Pageat, P. (1995) Pathologie du comportement du chien. Le Point Veterinaire, Paris.
[23]  Noli, C. (2019) Assessing Quality of Life for Pets with Dermatologic Disease and Their Owners. Veterinary Clinics of North America: Small Animal Practice, 49, 83-93.
https://doi.org/10.1016/j.cvsm.2018.08.008
[24]  Wojciechowska, J.I. and Hewson, C.J. (2005) Quality-of-Life Assessment in Pet Dogs. Journal of the American Veterinary Medical Association, 226, 722-728.
https://doi.org/10.2460/javma.2005.226.722
[25]  Noli, C., Colombo, S., Cornegliani, L., Ghibaudo, G., Persico, P. and Vercelli, A. (2011) Quality of Life of Dogs with Skin Disease and of Their Owners. Part 2: Administration of a Questionnaire in Various Skin Diseases and Correlation to Efficacy of Therapy. Veterinary Dermatology, 22, 344-351.
https://doi.org/10.1111/j.1365-3164.2011.00956.x
[26]  Maddison, J., Cannon, M., Davies, R., Farquhar, R., Faulkner, B., Furtado, T., Harvey, G., Leathers, F., Snowden, A. and Wright, I. (2021) Owner Compliance in Veterinary Practice: Recommendations from a Roundtable Discussion. Companion Animal, 26, S1-S11.
https://doi.org/10.12968/coan.2021.0029
[27]  Craven, A.J., Pegram, C., Packer, R.M.A., Jarvis, S., McGreevy, P.D., Warnes, C., Church, D.B., Brodbelt, D.C. and O’Neill, D.G. (2022) Veterinary Drug Therapies Used for Undesirable Behaviours in UK Dogs under Primary Veterinary Care. PLOS ONE, 17, e0261139.
https://doi.org/10.1371/journal.pone.0261139
[28]  Sargisson, R. (2014) Canine Separation Anxiety: Strategies for Treatment and Management. Veterinary Medicine: Research and Reports, 5, 143-151.
https://doi.org/10.2147/VMRR.S60424

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413